New lung cancer drug turns body into a tumour-fighting weapon

Commenting on the trial results of Nivolumab, an immune-boosting drug, Dr Martin Forster (UCL Research Department of Oncology) said: "These drugs will be a paradigm shift in how we treat lung cancer". Read: Daily Mail